Skip to main content
NCBI home page
Protein & Cell logoLink to Protein & Cell
. 2010 Jul 7;1(6):595–603. doi: 10.1007/s13238-010-0070-6

Crystal structure of the C-terminal domain of the ɛ subunit of human translation initiation factor eIF2B

Jia Wei 1,2, Minze Jia 1, Cheng Zhang 1, Mingzhu Wang 1, Feng Gao 1, Hang Xu 1,✉, Weimin Gong 1,✉
PMCID: PMC4875318  PMID: 21204011

Abstract

Eukaryotic translation initiation factor eIF2B, the guanine nucleotide exchange factor (GEF) for eIF2, catalyzes conversion of eIF2·GDP to eIF2·GTP. The eIF2B is composed of five subunits, α, β, γ, δ and ɛ, within which the ɛ subunit is responsible for catalyzing the guanine exchange reaction. Here we present the crystal structure of the C-terminal domain of human eIF2Bɛ (eIF2Bɛ-CTD) at 2.0-Å resolution. The structure resembles a HEAT motif and three charge-rich areas on its surface can be identified. When compared to yeast eIF2Bɛ-CTD, one area involves highly conserved AA boxes while the other two are only partially conserved. In addition, the previously reported mutations in human eIF2Bɛ-CTD, which are related to the loss of the GEF activity and human VWM disease, have been discussed. Based on the structure, most of such mutations tend to destabilize the HEAT motif.

Keywords: eukaryotic translation initiation factor 2B (eIF2B), guanine nucleotide exchange factor (GEF), crystal structure, HEAT motif, vanishing white matter (VWM)

Contributor Information

Hang Xu, Email: hxu@moon.ibp.ac.cn.

Weimin Gong, Email: wgong@ibp.ac.cn.

References

  1. Asano K., Krishnamoorthy T., Phan L., Pavitt G.D., Hinnebusch A.G. Conserved bipartite motifs in yeast eIF5 and eIF2Bepsilon, GTPase-activating and GDP-GTP exchange factors in translation initiation, mediate binding to their common substrate eIF2. EMBO J. 1999;18:1673–1688. doi: 10.1093/emboj/18.6.1673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Baker N.A., Sept D., Joseph S., Holst M.J., McCammon J.A. Electrostatics of nanosystems: application to microtubules and the ribosome. Proc Natl Acad Sci U S A. 2001;98:10037–10041. doi: 10.1073/pnas.181342398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bieniossek C., Schütz P., Bumann M., Limacher A., Uson I., Baumann U. The crystal structure of the carboxy-terminal domain of human translation initiation factor eIF5. J Mol Biol. 2006;360:457–465. doi: 10.1016/j.jmb.2006.05.021. [DOI] [PubMed] [Google Scholar]
  4. Boesen T., Mohammad S.S., Pavitt G.D., Andersen G.R. Structure of the catalytic fragment of translation initiation factor 2B and identification of a critically important catalytic residue. J Biol Chem. 2004;279:10584–10592. doi: 10.1074/jbc.M311055200. [DOI] [PubMed] [Google Scholar]
  5. Brunger A.T. Version 1.2 of the Crystallography and NMR system. Nat Protoc. 2007;2:2728–2733. doi: 10.1038/nprot.2007.406. [DOI] [PubMed] [Google Scholar]
  6. Brunger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., Grosse-Kunstleve R.W., Jiang J.S., Kuszewski J., Nilges M., Pannu N.S., et al. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. 1998;54:905–921. doi: 10.1107/S0108767398011465. [DOI] [PubMed] [Google Scholar]
  7. Cigan A.M., Bushman J.L., Boal T.R., Hinnebusch A.G. A protein complex of translational regulators of GCN4 mRNA is the guanine nucleotide-exchange factor for translation initiation factor 2 in yeast. Proc Natl Acad Sci U S A. 1993;90:5350–5354. doi: 10.1073/pnas.90.11.5350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Das S., Maiti T., Das K., Maitra U. Specific interaction of eukaryotic translation initiation factor 5 (eIF5) with the beta-subunit of eIF2. J Biol Chem. 1997;272:31712–31718. doi: 10.1074/jbc.272.50.31712. [DOI] [PubMed] [Google Scholar]
  9. Das S., Maitra U. Mutational analysis of mammalian translation initiation factor 5 (eIF5): role of interaction between the beta subunit of eIF2 and eIF5 in eIF5 function in vitro and in vivo. Mol Cell Biol. 2000;20:3942–3950. doi: 10.1128/MCB.20.11.3942-3950.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Dever T.E. Gene-specific regulation by general translation factors. Cell. 2002;108:545–556. doi: 10.1016/S0092-8674(02)00642-6. [DOI] [PubMed] [Google Scholar]
  11. Emsley P., Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr. 2004;60:2126–2132. doi: 10.1107/S0907444904019158. [DOI] [PubMed] [Google Scholar]
  12. Eswar, N., Webb, B., Marti-Renom, M.A., Madhusudhan, M.S., Eramian, D., Shen, M.Y., Pieper, U., and Sali, A. (2006). Comparative protein structure modeling using Modeller. Curr Protoc Bioinformatics Chapter 5, Unit 5.6. [DOI] [PMC free article] [PubMed]
  13. Fiser A., Do R.K., Sali A. Modeling of loops in protein structures. Protein Sci. 2000;9:1753–1773. doi: 10.1110/ps.9.9.1753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Fogli A., Boespflug-Tanguy O. The large spectrum of eIF2B-related diseases. Biochem Soc Trans. 2006;34:22–29. doi: 10.1042/BST0340022. [DOI] [PubMed] [Google Scholar]
  15. Gomez E., Mohammad S.S., Pavitt G.D. Characterization of the minimal catalytic domain within eIF2B: the guanine-nucleotide exchange factor for translation initiation. EMBO J. 2002;21:5292–5301. doi: 10.1093/emboj/cdf515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gouet P., Courcelle E., Stuart D.I., Métoz F. ESPript: analysis of multiple sequence alignments in PostScript. Bioinformatics. 1999;15:305–308. doi: 10.1093/bioinformatics/15.4.305. [DOI] [PubMed] [Google Scholar]
  17. Hinnebusch A.G. Translational regulation of GCN4 and the general amino acid control of yeast. Annu Rev Microbiol. 2005;59:407–450. doi: 10.1146/annurev.micro.59.031805.133833. [DOI] [PubMed] [Google Scholar]
  18. Holm L., Park J. DaliLite workbench for protein structure comparison. Bioinformatics. 2000;16:566–567. doi: 10.1093/bioinformatics/16.6.566. [DOI] [PubMed] [Google Scholar]
  19. Kapp L.D., Lorsch J.R. The molecular mechanics of eukaryotic translation. Annu Rev Biochem. 2004;73:657–704. doi: 10.1146/annurev.biochem.73.030403.080419. [DOI] [PubMed] [Google Scholar]
  20. Krishnamoorthy T., Pavitt G.D., Zhang F., Dever T.E., Hinnebusch A.G. Tight binding of the phosphorylated alpha subunit of initiation factor 2 (eIF2alpha) to the regulatory subunits of guanine nucleotide exchange factor eIF2B is required for inhibition of translation initiation. Mol Cell Biol. 2001;21:5018–5030. doi: 10.1128/MCB.21.15.5018-5030.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Larkin M.A., Blackshields G., Brown N.P., Chenna R., McGettigan P.A., McWilliam H., Valentin F., Wallace I.M., Wilm A., Lopez R., et al. Clustal W and Clustal X version 2.0. Bioinformatics. 2007;23:2947–2948. doi: 10.1093/bioinformatics/btm404. [DOI] [PubMed] [Google Scholar]
  22. Li W., Wang X., Van Der Knaap M.S., Proud C.G. Mutations linked to leukoencephalopathy with vanishing white matter impair the function of the eukaryotic initiation factor 2B complex in diverse ways. Mol Cell Biol. 2004;24:3295–3306. doi: 10.1128/MCB.24.8.3295-3306.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Maletkovic J., Schiffmann R., Gorospe J.R., Gordon E.S., Mintz M., Hoffman E.P., Alper G., Lynch D.R., Singhal B.S., Harding C., et al. Genetic and clinical heterogeneity in eIF2B-related disorder. J Child Neurol. 2008;23:205–215. doi: 10.1177/0883073807308705. [DOI] [PubMed] [Google Scholar]
  24. Marcotrigiano J., Lomakin I.B., Sonenberg N., Pestova T.V., Hellen C.U., Burley S.K. A conserved HEAT domain within eIF4G directs assembly of the translation initiation machinery. Mol Cell. 2001;7:193–203. doi: 10.1016/S1097-2765(01)00167-8. [DOI] [PubMed] [Google Scholar]
  25. Marintchev A., Wagner G. Translation initiation: structures, mechanisms and evolution. Q Rev Biophys. 2004;37:197–284. doi: 10.1017/S0033583505004026. [DOI] [PubMed] [Google Scholar]
  26. Martí-Renom M.A., Stuart A.C., Fiser A., Sánchez R., Melo F., Sali A. Comparative protein structure modeling of genes and genomes. Annu Rev Biophys Biomol Struct. 2000;29:291–325. doi: 10.1146/annurev.biophys.29.1.291. [DOI] [PubMed] [Google Scholar]
  27. Mohammad-Qureshi S.S., Haddad R., Hemingway E.J., Richardson J.P., Pavitt G.D. Critical contacts between the eukaryotic initiation factor 2B (eIF2B) catalytic domain and both eIF2beta and-2gamma mediate guanine nucleotide exchange. Mol Cell Biol. 2007;27:5225–5234. doi: 10.1128/MCB.00495-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Mohammad-Qureshi S.S., Haddad R., Palmer K.S., Richardson J. P., Gomez E., Pavitt G.D. Purification of FLAG-tagged eukaryotic initiation factor 2B complexes, subcomplexes, and fragments from Saccharomyces cerevisiae. Methods Enzymol. 2007;431:1–13. doi: 10.1016/S0076-6879(07)31001-X. [DOI] [PubMed] [Google Scholar]
  29. Mohammad-Qureshi S.S., Jennings M.D., Pavitt G.D. Clues to the mechanism of action of eIF2B, the guanine-nucleotide-exchange factor for translation initiation. Biochem Soc Trans. 2008;36:658–664. doi: 10.1042/BST0360658. [DOI] [PubMed] [Google Scholar]
  30. Murshudov G.N., Vagin A.A., Dodson E.J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. 1997;53:240–255. doi: 10.1107/S0907444996012255. [DOI] [PubMed] [Google Scholar]
  31. Otwinowski Z., Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 1997;276:307–326. doi: 10.1016/S0076-6879(97)76066-X. [DOI] [PubMed] [Google Scholar]
  32. Pavitt G.D. eIF2B, a mediator of general and gene-specific translational control. Biochem Soc Trans. 2005;33:1487–1492. doi: 10.1042/BST0331487. [DOI] [PubMed] [Google Scholar]
  33. Pavitt G.D., Ramaiah K.V., Kimball S.R., Hinnebusch A.G. eIF2 independently binds two distinct eIF2B subcomplexes that catalyze and regulate guanine-nucleotide exchange. Genes Dev. 1998;12:514–526. doi: 10.1101/gad.12.4.514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Sali A., Blundell T.L. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol. 1993;234:779–815. doi: 10.1006/jmbi.1993.1626. [DOI] [PubMed] [Google Scholar]
  35. Scali O., Di Perri C., Federico A. The spectrum of mutations for the diagnosis of vanishing white matter disease. Neurol Sci. 2006;27:271–277. doi: 10.1007/s10072-006-0683-y. [DOI] [PubMed] [Google Scholar]
  36. Singh C.R., Lee B., Udagawa T., Mohammad-Qureshi S.S., Yamamoto Y., Pavitt G.D., Asano K. An eIF5/eIF2 complex antagonizes guanine nucleotide exchange by eIF2B during translation initiation. EMBO J. 2006;25:4537–4546. doi: 10.1038/sj.emboj.7601339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Smirnova J.B., Selley J.N., Sanchez-Cabo F., Carroll K., Eddy A. A., McCarthy J.E., Hubbard S.J., Pavitt G.D., Grant C.M., Ashe M.P. Global gene expression profiling reveals widespread yet distinctive translational responses to different eukaryotic translation initiation factor 2B-targeting stress pathways. Mol Cell Biol. 2005;25:9340–9349. doi: 10.1128/MCB.25.21.9340-9349.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Sonenberg N., Hinnebusch A.G. New modes of translational control in development, behavior, and disease. Mol Cell. 2007;28:721–729. doi: 10.1016/j.molcel.2007.11.018. [DOI] [PubMed] [Google Scholar]
  39. Terwilliger T.C. Maximum-likelihood density modification. Acta Crystallogr. 2000;56:965–972. doi: 10.1107/S0907444900005072. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Terwilliger T.C. Automated main-chain model building by template matching and iterative fragment extension. Acta Crystallogr. 2003;59:38–44. doi: 10.1107/S0907444902018036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Terwilliger T.C., Berendzen J. Automated MAD and MIR structure solution. Acta Crystallogr. 1999;55:849–861. doi: 10.1107/S0108768199005194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Wang X., Paulin F.E., Campbell L.E., Gomez E., O’Brien K., Morrice N., Proud C.G. Eukaryotic initiation factor 2B: identification of multiple phosphorylation sites in the epsilon-subunit and their functions in vivo. EMBO J. 2001;20:4349–4359. doi: 10.1093/emboj/20.16.4349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Wang X., Proud C.G. A novel mechanism for the control of translation initiation by amino acids, mediated by phosphorylation of eukaryotic initiation factor 2B. Mol Cell Biol. 2008;28:1429–1442. doi: 10.1128/MCB.01512-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Wei Z., Xue Y., Xu H., Gong W. Crystal structure of the C-terminal domain of S.cerevisiae eIF5. J Mol Biol. 2006;359:1–9. doi: 10.1016/j.jmb.2006.03.037. [DOI] [PubMed] [Google Scholar]
  45. Williams D.D., Pavitt G.D., Proud C.G. Characterization of the initiation factor eIF2B and its regulation in Drosophila melanogaster. J Biol Chem. 2001;276:3733–3742. doi: 10.1074/jbc.M008041200. [DOI] [PubMed] [Google Scholar]
  46. Williams D.D., Price N.T., Loughlin A.J., Proud C.G. Characterization of the mammalian initiation factor eIF2B complex as a GDP dissociation stimulator protein. J Biol Chem. 2001;276:24697–24703. doi: 10.1074/jbc.M011788200. [DOI] [PubMed] [Google Scholar]
  47. Wu Y., Pan Y., Du L., Wang J., Gu Q., Gao Z., Li J., Leng X., Qin J., Wu X., et al. Identification of novel EIF2B mutations in Chinese patients with vanishing white matter disease. J Hum Genet. 2009;54:74–77. doi: 10.1038/jhg.2008.10. [DOI] [PubMed] [Google Scholar]

Articles from Protein & Cell are provided here courtesy of Oxford University Press

RESOURCES

HHS Vulnerability Disclosure